A novel finding of our study is that the expression of SLC7A5, a major transporter of EAA, is markedly increased in circulating monocytes in RA patients and this positively correlates with clinical parameters, including IL-1β levels in plasma (Figures 1 and 6). Here, SLC7A5 is linked to rheumatoid arthritis.